A director at Valens Semiconductor Ltd sold 42,017 shares at 2.090USD and the significance rating of the trade was 56/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years...
Two Directors at Blackrock Silver Corp sold 379,000 shares at between 1.411CAD and 1.413CAD. The significance rating of the trade was 61/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over...
Two Directors at Jordanian RealEstate for Development bought 641,108 shares at 0.000JOD. The significance rating of the trade was 88/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the...
Bagoe Update Perth, Jan. 19, 2026 (GLOBE NEWSWIRE) -- BAGOÉ ACCIDENT UPDATE Perth, Western Australia/January 19, 2026/Perseus Mining Limited (ASX/TSX: PRU) regrets to advise that, following the announcement of a fatal offsite vehicle accident that occurred last Thursday January 15 near our Bagoé Gold Mine in Côte d’Ivoire, another occupant in that vehicle, also an employee of our contractor company Binkadi, who was receiving care in hospital, has passed away. The other passengers in the vehicle sustained minor injuries and have been released from hospital. We extend our deepest sympathi...
Fundamentals taking over – Greek equities delivered an exceptional performance in 2025, emerging as one of the strongest markets globally, with the ASE General Index up c50%. This marked the 4th consecutive year of outperformance vs the Euro Stoxx 600, a streak not witnessed in the past two decades. The magnitude of the 2025 rally inevitably sets a high base heading into 2026 (especially since the ASE is already up c6% ytd). As a result, we believe the market will transition from a beta-driven p...
A director at Socovesa Sa sold 1,020,000 shares at 140.569CLP and the significance rating of the trade was 61/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
A director at GFH Financial Group B.S.C bought 1,100,000 shares at 0.580USD and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last tw...
A director at Westpac Banking Corporation sold 4,825 shares at 38.384AUD and the significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two ye...
Q4 2025 Trading Update and Invitation to Earnings Call Oslo, 19 January 2026 – DNO ASA, the Norwegian oil and gas operator, will publish its Q4 2025 operating and interim financial results on 5 February at 07:00 (CET). A videoconference call with executive management will follow at 10:00 (CET). Today, the Company provides an update on production, sales volumes and other selected information for the quarter. Volumes (boepd) Gross operated productionQ4 2025Q3 2025Q4 2024Kurdistan77,26846,57274,163North Sea10,55511,5086,602 Net entitlement productionQ4 2025Q3 2025Q4 2024Kurdistan20,0191...
Aktsiaselts Infortar own share acquisition transactions Aktsiaselts Infortar acquired its own shares on the Nasdaq Tallinn Stock Exchange during the period of 12 – 16 January 2026 as follows: DateAggregated volume (pcs)Weighted average price per day (EUR)12.01.202621045,500013.01.202620545,476614.01.202620545,400015.01.202620645,490316.01.202620745,4758 Aktsiaselts Infortar is acquiring its own shares based on the stock exchange announcement . The share buyback programme is managed by SEB Pank AS, which will buy back shares on behalf of Aktsiaselts Infortar. Summary data (daily volume and ...
Aktsiaseltsi Infortar oma aktsiate omandamise tehingud Aktsiaselts Infortar on perioodil 12 - 16. jaanuar 2026 omandanud Nasdaq Tallinna börsil oma aktsiaid alljärgnevalt: KuupäevKoondmaht (tk)Kaalutud keskmine päevahind (EUR)12.01.202621045,500013.01.202620545,476614.01.202620545,400015.01.202620645,490316.01.202620745,4758 Aktsiaselts Infortar omandab oma aktsiaid vastavalt . Aktsiate tagasiostu täideviijaks ja korraldajaks on AS SEB Pank, kes teostab aktsiate tagasiostu Aktsiaseltsi Infortar nimel. Omandamiste koondandmed (omandatud aktsiate kogus ja kaalutud keskmine hind päeva kaupa) ...
IBA selected by MD Anderson Cancer Center to supply three Proteus®ONE systems Louvain-La-Neuve, Belgium, January 19, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and leading provider of proton therapy solutions for the treatment of cancer, today announced that it has signed a contract with the University of Texas MD Anderson Cancer Center, ranked #1 in cancer care by U.S. News & World Report, to re-equip and modernize its existing Proton Therapy Center in Houston with three state-of-the-art Proteus®ONE1 systems. IBA was awarded th...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.